Dividends Inside Welcome to Dividends Inside
Welcome to Dividends Inside!
The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.
Welcome to Dividends Inside!
The platform is currently in beta, so some features and data may still change as we improve the service. If you have questions, feedback, or run into anything unexpected, please contact us at info@dividendsinside.com.
Allscripts Healthcare Solutions Inc
MDRX
$4.75 (- $0.35 - 6.86%)
Last updated: Previous Close (2026-05-19)
About the Company
Veradigm Inc. is a healthcare technology company specializing in data-driven solutions that connect providers, payers, and life science organizations. The company’s core offerings include electronic health records (EHR), practice management software, and analytics tools designed to optimize clinical, financial, and operational outcomes. It serves over 180,000 physicians and supports 2,700 hospitals through platforms that enhance care coordination, patient engagement, and population health management. Veradigm leverages its extensive healthcare data network to deliver actionable insights for clinical research, revenue cycle management, and value-based care initiatives. Historically known as Allscripts, the company rebranded in 2023 to reflect its focus on scalable, AI-enhanced solutions. Despite recent regulatory challenges, including a 2024 Nasdaq suspension for delayed financial filings, Veradigm remains a significant player in healthcare IT, bridging gaps across the ecosystem through interoperable technology and data interoperability standards.
Price History
Latest News for MDRX
Veradigm avoids enforcement action in SEC probe
The investigation began after the health IT company failed to comply with financial reporting requirements, which led to its delisting from the Nasdaq in early 2024.
Veradigm cut 15% of its workforce in 2025
The health IT firm is also cutting back on offices and “low revenue” products as it works to get up to date on its financial filings with regulators, executives said during a call this week.
Veradigm Provides Business and Strategy Update
CHICAGO, February 17, 2026--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal year 2025 and key areas of strategic focus for 2026.
$555+ Mn AI in Patient Scheduling Software Market Forecast to 2033 Featuring Veradigm, Epic Systems, Hyro, Assort Health, Notable, Voiceoc, Zocdoc, Relatient, and UnityAI
The AI in patient scheduling software market is primed for growth, driven by the need to reduce inefficiencies and improve patient-centric care. Key opportunities include optimizing resource use, enhancing digital patient engagement, and facilitating telehealth. The rise of value-based care further amplifies AI scheduling adoption. AI in Patient Scheduling Software Market AI in Patient Scheduling Software Market Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "AI in Patient Scheduling Software Mar
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
CHICAGO, February 13, 2026--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey capability that brings the patient voice directly into real‑world evidence generation. The new solution gives life sciences organizations timely, privacy‑preserving insights directly from patients, adding essential context to clinical and observational research.
Veradigm to Release Business Update February 17th and Host Investor Call February 18th
CHICAGO, February 10, 2026--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business update after the close of regular stock market hours on February 17, 2026. Veradigm management plans to host an investor conference call and webcast to discuss the Company’s update at 8:00 a.m. Eastern Time on February 18, 2026.